Screening Resources
Detecting type 1 diabetes early can help prevent diabetic ketoacidosis (DKA)
DKA is a potentially life-threatening condition, which people often experience at the time they are diagnosed with diabetes.
By detecting T1D long before blood sugar levels rise and symptoms develop, you may be able to avoid DKA and protect yourself and your loved ones from its dangerous consequences.
Screening How To - It only takes a blood test to detect the earliest stages of T1D. There are a few options for getting screened, which are linked below.
Screening Results
The Stages of T1D are related to the number autoantibodies present combined with blood glucose levels. These stages can take months or years to develop.
Spotting the earliest stages of T1D is so important.
Preventing diabetic ketoacidosis (DKA) protects brain health and saves lives. Diagnosing T1D before blood glucose levels rise and insulin production plummets — leading to diabetes ketoacidosis — can have tremendous benefits.
DKA is a potentially life-threatening condition, which people often experience at the time they are diagnosed with diabetes. Research has also found that DKA at diagnosis can permanently injure the brain.
Detecting T1D early and monitoring autoantibodies over time means preventing DKA.
What to do next:
Our Research on T1D Autoantibody Screening
Operationalizing Early-Stage Type 1 Diabetes Screening and Monitoring: A Pediatric Multicenter T1D Exchange Quality Improvement Initiative
Presented at ADA 2026 and published in Diabetes Journal.
Beta-Cell Preservation Throughout the Stages of Type 1 Diabetes White Paper
Developed with clinical leaders from the T1D Exchange Quality Improvement Collaborative and grounded in current evidence and real-world implementation experience.
Beta-Cell Preservation in the Wild—Need for Real-World Monitoring, Treatment Protocols, and Efficacy Measures of Potential Disease Modifying Therapies in Type 1 Diabetes
Health Care Provider Awareness and Attitudes Towards Type 1 Diabetes Antibody Screening
Bringing early detection to life: real-world operationalization of a presymptomatic type 1 diabetes screening and monitoring pilot program
Published in BMJ Open Diabetes Research & Care on May 2, 2026.
Exploring Attitudes toward Autoantibody Screening in People Living with T1D, Caregivers, and First-Degree Relatives
Autoantibody Screening Attitudes and Experiences in People Affected by Type 1 Diabetes
T1D Autoantibody Screening Resources
This content was developed independently by T1D Exchange and was supported by a healthcare contribution from Sanofi.
DISCLAIMER: The information on this webpage is not intended to replace medical guidance from your health care provider. T1D Exchange recommends using the above resources with expert guidance from your healthcare provider.
Positive autoantibody tests should be followed up with additional testing to confirm the results under the guidance of your healthcare provider.